Mendoza TLA, Acuña PM, Rueda GDM, Gallego HKP, Vásquez MMF, Celis QJL, de León SJC

Language: Spanish
References: 26
Page:
PDF size: 124.87 Kb.

ABSTRACT

Objective: to compare the short-term morbidity, the number of interventions, the length of stay at hospital and the incurred costs between 34-weeks neonates and over-34 weeks newborns, who had been admitted to the neonatal intensive care units of Fundacion Hospital San Jose de Buga in Colombia from September 19th 2005 to September 18th 2011.
Methods: retrospective cohort study in forty 34-weeks newborns and one hundred twenty nine 35-36 weeks neonates. Maternal and neonatal factors as well as applied therapies were evaluated. The analysis covered summary statistics and bivariate analysis. For finding association, the relative risk with 95 % confidence interval, and the Pearson's chi square test of independence were used.
Results: respiratory morbidity was found in 32.5 % of patients, jaundice in 29 %, gastrointestinal morbidity in 13.6 %, metabolic morbidity in 13.6 %, cardiac morbidity in 1.8 %, hematological morbidity in 1.2 % and hypothermia and sepsis were seen in 1.2 % of patients. Renal failure affected 0.6 % of neonates, without statistical difference between the groups. There was statistically significant difference (p< 0,05) for fasting time (over 2 days), parenteral nutrition and time of oxygen therapy (more than 2 and 5 days, respectively), time of mechanical ventilation and long stays at hospital (over 7 days); the 34-weeks neonates were the most affected in terms of morbidity. Weight, size and head perimeter figures at birth and at discharge from the hospital were lower in the 34 weeks group, whereas the delayed intrauterine growth was greater in the 35 and 36 weeks neonates (26,4 vs. 7,5 %; RR: 1,3; IC 95 %: 1,1-1,5; p< 0,05). The care of 34 week neonates at hospital is, therefore, 1.6 and 0.6 times more expensive than that of 35 and 36-weeks newborns.
Conclusions: the late preterm infant should be considered as immature with morbidity and mortality risks. The incidence of jaundice, respiratory, gastrointestinal and metabolic morbidities is high; however, the 34-week newborns require more interventions than the 35 and 36 weeks neonates.

REFERENCES

1. Kramer MS, Demissie K, Yang H, Platt RW, Sauvé R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA. 2000;284(7):843-9.

2. Klebanoff MA. Conceptualizing categories of preterm birth. Prenat Neonatal Med. 1998;3(1):13-5.

3. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118:1207-14.

4. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2008. Natl Vital Stat Rep. 2010;58(16):1-17.

5. Adamkin D. Late preterm infants: severe hyperbilirubinemia and postnatal glucose homeostasis. J Perinatol. 2009;29:S12-7.

6. Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol. 2004;104(1):78-87.

7. Joseph KS. Obstetric intervention, stillbirth, and preterm birth. Semin Perinatol. 2002;26(4):250-9.

8. Laptook A, Jackson GL. Cold Stress and hypoglycemia in the late preterm ("near-term") infant: impact on nursery of admission. Semin Perinatol. 2006;30:24-7.

9. Neu J. Gastrointestinal maturation and feeding. Semin Perinatol. 2006;30:77-80.

10. Kien CL, McClead RE, Cordero L Jr. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants. J Pediatr. 1998;133:401-5.

11. Gartner LM, Herschel M. Jaundice and breastfeeding. Pediatr Clin North Am. 2002;48:389-99.

12. Ward RM. Drug disposition in the late preterm ("near-term") newborn. Semin Perinatol. 2006;30:48-59.

13. Clapp DW. Developmental regulation of the immune system. Semin Perinatol. 2006;30:69-72.

14. Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B. Annual summary of vital statistics: 2004. Pediatrics. 2006;117:168-83.

15. Watchko JF. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol. 2006;33:839-52.

16. Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatr Clin North Am. 2009;56:671-87.

17. Bhutani VK, Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol. 2006;30:89-97.

18. McIntire D, Leveno K. Neonatal Mortality and Morbidity Rates in Late Preterm Births Compared With Births at Term. Obstetrics & Gynecology. 2008;111(1):35-41.

19. Cohen-Wolkowiez M, Moran C, Benjamin D, Cotten CM, Clark RH, Benjamin DK Jr, et al. Early and Late Onset Sepsis in Late Preterm Infants. Ped Infect Dis. 2009;28:1052-6.

20. Pulver L, Denney J, Silver R, Young P. Morbidity and Discharge Timing of Late Preterm Newborns. Clinical Pediatrics. 2010;49:1061-7.

21. Engle W. Morbidity and Mortality in Late Preterm and Early Term Newborns: A Continuum. Clin Perinatol. 2011;38:493-516.

22. Mohan S, Jain L. Late Preterm Birth: Preventable Prematurity? Clin Perinatol. 2011;38:547-55.

23. Rojas P, Pavón A, Rosso M, Losada A. Complicaciones a corto plazo de los recién nacidos pretérmino tardíos. An Pediatr (Barc). 2011;75(3):169-74.

24. Lupiani P, Pozo E, Alvarez N, Cerrudo P, Cerrudo P, López S. Prematuros tardios. Problemas y seguimiento en Atencion Primaria. Can Pediatr. 2011;35(2):109-14.

25. Hanson L, Korotkova M, Lundin S. The transfer of immunity from mother to child. Annals of New York Academy of Sciences. 2003;987:199-206.

26. Demestre X, Raspall F, Martinez S, Vila C, Elizari MJ, Sala P. Prematuros tardíos: una población de riesgo infravalorada. An Pediatr (Barc). 2009;71(4):291-8.